Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia Nervosa

Sponsor
University of Minnesota (Other)
Overall Status
Completed
CT.gov ID
NCT02148042
Collaborator
(none)
26
1
27
1

Study Details

Study Description

Brief Summary

Anorexia nervosa is a chronic mental health condition characterized by maladaptive food consumption (i.e., hypophagia) and distorted body image. There is substantial evidence of a phenotypic overlap between anorexia nervosa and anxiety disorders, as well as data suggesting the two share a common genetic pathway. Despite these findings, little research has examined fear conditioning among individuals with anorexia nervosa, and no research has examined whether individuals with anorexia nervosa have a propensity to overgeneralize conditioned fear stimuli, one of the more robust fear-conditioning markers of anxiety disorders. The current study assesses generalization of conditioned fear with fear-potentiated startle: the cross-species enhancement of the startle reflex when an organism is in a state of fear. Animal data, as well as an emerging literature in humans, tightly links fear-potentiated startle to the amygdala-based fear circuit. Thus, evidence of overgeneralized fear-potentiated startle in anorexia nervosa would link this eating disorder to hypersensitivity of the fear circuit and could inform the development of novel pharmacologic and psychological treatments for anorexia nervosa based on treatment models used in the anxiety disorders literature.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The overarching objective of the current proposal is to examine the feasibility of applying a generalization of conditioned fear-potentiated startle paradigm, which has been used successfully to measure the sensitivity of fear networks in anxiety disorders, to adults with anorexia nervosa. The specific aim will be to examine whether conditioned-fear generalization gradients in anorexia nervosa participants differ from those in healthy controls. It is hypothesized that anorexia nervosa participants will display stronger generalization as indicated by less quadratic generalization gradients (i.e., a more gradual decline in conditioned fear as the generalization stimuli deviate from the conditioned fearful stimuli), which is indicative of a heightened sensitivity, or lower thresholds of activation, in the fear circuit (i.e., less danger information necessary to trigger the fear).

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    26 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia Nervosa
    Study Start Date :
    Apr 1, 2014
    Actual Primary Completion Date :
    Jul 1, 2016
    Actual Study Completion Date :
    Jul 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    Anorexics

    Controls

    Outcome Measures

    Primary Outcome Measures

    1. The primary outcome variable is startle response (eye blink). [Within 2 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Adults (ageā‰„18)
    1. Anorexics
    • Meet criteria for Diagnostic and Statistical Manual (DSM-5) anorexia nervosa
    1. Controls
    • age matched

    • sex-matched

    Exclusion Criteria:
    • Criteria are met for a current or past Axis I disorder.

    • Inability to read English

    • Pregnancy/lactation

    • Acute suicidality

    • Medical instability as determined by a medical history visit and serum electrolyte testing,

    • Medical conditions that may place the participant at risk (e.g., cardiovascular condition)

    • Current use of medication that alter central nervous system function

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Minnesota Minneapolis Minnesota United States 55455

    Sponsors and Collaborators

    • University of Minnesota

    Investigators

    • Principal Investigator: Kelly C. Berg, PhD, University of Minnesota

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Minnesota
    ClinicalTrials.gov Identifier:
    NCT02148042
    Other Study ID Numbers:
    • 1312M46141
    First Posted:
    May 28, 2014
    Last Update Posted:
    Jul 12, 2019
    Last Verified:
    Jul 1, 2019
    Keywords provided by University of Minnesota
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 12, 2019